Global /Australia /Industrials /Specialty Business Services /CTE
chevron_leftBack
Cryosite Ltd. logo

Cryosite Ltd.

CTE
ASX: CTE Delayed
1.15AUD 2.7%
0.8102 USD
As of 17 June 2026, Cryosite Ltd. has a market cap of $38.67M USD, ranking #32485 globally and #832 in Australia. It ranks #7412 in the Industrials sector, and #883 in the Specialty Business Services industry.
Global Rank
32485
Country Rank
832
Sector Rank
7412
Industry Rank
883
Key Stats
Market Cap
$38.67MUSD
54.67M AUD
Enterprise Value
$42.94MUSD
60.95M AUD
Revenue (TTM)
$11.14MUSD
15.75M AUD
EBITDA (TTM)
$2.42MUSD
3.44M AUD
Net Income (TTM)
$1.55MUSD
2.18M AUD
EBITDA Margin
22%
Profit Margin
14%
PE Ratio
26.1
PS Ratio
3.5
PB Ratio
15.1
EV/EBITDA
16.5
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
Employees
25
Founded
1999
Website
cryosite.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.7% 6.7% -2.6% 5.7% -14% 49%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
CTE
Cryosite Ltd
ISIN: AU000000CTE1
Shares Out.:
48.81M1
TV:
SA:
YF:
GF:
BA:
CTE
MS:
1.15 AUD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cryosite Ltd.

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements. The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage. The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls. It also offers reverse logistics services, secondary packaging, inventory management, and quality transportation and distribution solutions. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

Similar Companies

Industry: Specialty Business Services (Australia)
Name
Market Cap diff.
PE
$12.15B
17.18B AUD
31K%
19.3
ALQ
$7.59B
10.72B AUD
20K%
38.6
GNC
$940.31M
1.33B AUD
2K%
34.1
$845.08M
1.19B AUD
2K%
23.5
$832.6M
1.18B AUD
2K%
14.7
CCL
$677.38M
957.49M AUD
2K%
24.5
Industry: Specialty Business Services (Global)
Name
Market Cap diff.
PE
SHOP
$158.14B
409K%
129.8
VSURE
$133.11B
114.8B EUR
344K%
-
CTAS
$69.6B
180K%
36.8
REL
$63.88B
47.6B GBP
165K%
23.9
PYPL
$45.83B
118K%
9.4
$41.8B
56.91B CAD
108K%
-
chevron_leftBack